Envoy Net Receivables from 2010 to 2026

COCH Stock   0.52  0.14  21.21%   
Envoy Medical's Net Receivables is increasing with slightly volatile movements from year to year. Net Receivables is estimated to finish at about 987.7 K this year. For the period between 2010 and 2026, Envoy Medical, Net Receivables quarterly trend regression had mean deviation of  241,862 and range of 946.7 K. View All Fundamentals
 
Net Receivables  
First Reported
2010-12-31
Previous Quarter
940.7 K
Current Value
987.7 K
Quarterly Volatility
328.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Envoy Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Envoy Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.3 K, Other Operating Expenses of 11.9 M or Total Operating Expenses of 11.3 M, as well as many indicators such as Price To Sales Ratio of 258, Dividend Yield of 0.0729 or Days Sales Outstanding of 1.3 K. Envoy financial statements analysis is a perfect complement when working with Envoy Medical Valuation or Volatility modules.
  
Build AI portfolio with Envoy Stock
Check out the analysis of Envoy Medical Correlation against competitors.
For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.
The Net Receivables trend for Envoy Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Envoy Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Envoy Medical's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Envoy Medical over the last few years. It is Envoy Medical's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Envoy Medical's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Envoy Net Receivables Regression Statistics

Arithmetic Mean230,202
Geometric Mean125,425
Coefficient Of Variation142.77
Mean Deviation241,862
Median88,000
Standard Deviation328,661
Sample Variance108B
Range946.7K
R-Value0.65
Mean Square Error66.5B
R-Squared0.42
Significance0
Slope42,325
Total Sum of Squares1.7T

Envoy Net Receivables History

2026987.7 K
2025940.7 K
2024818 K
202370 K
202241 K

About Envoy Medical Financial Statements

Investors use fundamental indicators, such as Envoy Medical's Net Receivables, to determine how well the company is positioned to perform in the future. Although Envoy Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Receivables940.7 K987.7 K

Currently Active Assets on Macroaxis

When determining whether Envoy Medical is a strong investment it is important to analyze Envoy Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Envoy Medical's future performance. For an informed investment choice regarding Envoy Stock, refer to the following important reports:
Check out the analysis of Envoy Medical Correlation against competitors.
For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is there potential for Health Care Equipment & Supplies market expansion? Will Envoy introduce new products? Factors like these will boost the valuation of Envoy Medical. Projected growth potential of Envoy fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Envoy Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.37)
Revenue Per Share
0.01
Quarterly Revenue Growth
(0.25)
Return On Assets
(1.45)
Understanding Envoy Medical requires distinguishing between market price and book value, where the latter reflects Envoy's accounting equity. The concept of intrinsic value - what Envoy Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Envoy Medical's price substantially above or below its fundamental value.
It's important to distinguish between Envoy Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Envoy Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Envoy Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.